Clinical Trial Update: Phase I Clinical Study of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defect [Phase 1]

View source ↗

Summary

Phase I trial of ZKY001 Eye Drops for corneal epithelial defect has completed, evaluating its use in corneal diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Diseases
• Corneal Epithelial Defect

Drugs mentioned

• ZKY001 Eye Drops

Snippet

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Conditions: Corneal Diseases | Phase 1 | Status: COMPLETED